Our study showed that in patients with ASS-ILD with dyspnea and cough as the first symptoms, the levels of IgG and IgE and the number of CD16+ CD56+ (NK) cells were significantly different among the four different ASA groups. This evidence concerns the gene IGHE and interstitial lung disease.